Expert Consensus on Optimal Acquisition and Development of the International Bowel Ultrasound Segmental Activity Score [IBUS-SAS]: A Reliability and Inter-rater Variability Study on Intestinal Ultrasonography in Crohn's Disease.
Ultrasound
activity index
monitoring
reliability
Journal
Journal of Crohn's & colitis
ISSN: 1876-4479
Titre abrégé: J Crohns Colitis
Pays: England
ID NLM: 101318676
Informations de publication
Date de publication:
06 Apr 2021
06 Apr 2021
Historique:
pubmed:
25
10
2020
medline:
6
11
2021
entrez:
24
10
2020
Statut:
ppublish
Résumé
Intestinal ultrasound [IUS] is an accurate, patient-centreed monitoring tool that objectively evaluates Crohn's disease [CD] activity. However no current, widely accepted, reproducible activity index exists to facilitate consistent IUS identification of inflammatory activity. The aim of this study is to identify key parameters of CD inflammation on IUS, evaluate their reliability, and develop an IUS index reflecting segmental activity. There were three phases: [1] expert consensus Delphi method to derive measures of IUS activity; [2] an initial, multi-expert case acquisition and expert interpretation of 20 blinded cases, to measure inter-rater reliability for individual measures; [3] refinement of case acquisition and interpretation by 12 international experts, with 30 blinded case reads with reliability assessment and development of a segmental activity score. Delphi consensus: 11 experts representing seven countries identified four key parameters including: [1] bowel wall thickness [BWT]; [2] bowel wall stratification; [3] hyperaemia of the wall [colour Doppler imaging]; and [4] inflammatory mesenteric fat. Blind read: each variable exhibited moderate to substantial reliability. Optimal, standardised image and cineloop acquisition were established. Second blind read and score development: intra-class correlation coefficient [ICC] for BWT was almost perfect at 0.96 [0.94-0.98]. All four parameters correlated with the global disease activity assessment and were included in the final International Bowel Ultrasound Segmental Activity Score with almost perfect ICC (0.97 [0.95-0.99, p <0.001]). Using expert consensus and standardised approaches, identification of key activity measurements on IUS has been achieved and a segmental activity score has been proposed, demonstrating excellent reliability.
Sections du résumé
BACKGROUND AND AIMS
OBJECTIVE
Intestinal ultrasound [IUS] is an accurate, patient-centreed monitoring tool that objectively evaluates Crohn's disease [CD] activity. However no current, widely accepted, reproducible activity index exists to facilitate consistent IUS identification of inflammatory activity. The aim of this study is to identify key parameters of CD inflammation on IUS, evaluate their reliability, and develop an IUS index reflecting segmental activity.
METHODS
METHODS
There were three phases: [1] expert consensus Delphi method to derive measures of IUS activity; [2] an initial, multi-expert case acquisition and expert interpretation of 20 blinded cases, to measure inter-rater reliability for individual measures; [3] refinement of case acquisition and interpretation by 12 international experts, with 30 blinded case reads with reliability assessment and development of a segmental activity score.
RESULTS
RESULTS
Delphi consensus: 11 experts representing seven countries identified four key parameters including: [1] bowel wall thickness [BWT]; [2] bowel wall stratification; [3] hyperaemia of the wall [colour Doppler imaging]; and [4] inflammatory mesenteric fat. Blind read: each variable exhibited moderate to substantial reliability. Optimal, standardised image and cineloop acquisition were established. Second blind read and score development: intra-class correlation coefficient [ICC] for BWT was almost perfect at 0.96 [0.94-0.98]. All four parameters correlated with the global disease activity assessment and were included in the final International Bowel Ultrasound Segmental Activity Score with almost perfect ICC (0.97 [0.95-0.99, p <0.001]).
CONCLUSIONS
CONCLUSIONS
Using expert consensus and standardised approaches, identification of key activity measurements on IUS has been achieved and a segmental activity score has been proposed, demonstrating excellent reliability.
Identifiants
pubmed: 33098642
pii: 5938527
doi: 10.1093/ecco-jcc/jjaa216
pmc: PMC8023841
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
609-616Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation.
Références
Dig Liver Dis. 2008 Nov;40(11):860-6
pubmed: 18583205
Gastroenterology. 1976 Mar;70(3):439-44
pubmed: 1248701
Eur Radiol. 2019 Mar;29(3):1083-1093
pubmed: 30128615
Inflamm Bowel Dis. 2016 May;22(5):1168-83
pubmed: 26958988
J Crohns Colitis. 2016 Sep;10 Suppl 2:S542-7
pubmed: 27604978
Aliment Pharmacol Ther. 2020 Nov;52(10):1563-1573
pubmed: 32886809
Inflamm Bowel Dis. 2017 Nov;23(11):2001-2010
pubmed: 28644185
Ultraschall Med. 2017 Jun;38(3):e1-e15
pubmed: 27604052
J Crohns Colitis. 2019 Feb 1;13(2):144-164
pubmed: 30137275
Aliment Pharmacol Ther. 2003 Oct 1;18(7):749-56
pubmed: 14510749
Inflamm Bowel Dis. 2011 Jun;17(6):1415-22
pubmed: 21560202
Clin Gastroenterol Hepatol. 2020 May;18(6):1300-1308
pubmed: 31887449
Br J Radiol. 2019 Jul;92(1099):20180930
pubmed: 31141389
Inflamm Bowel Dis. 2018 Aug 16;24(9):2001-2006
pubmed: 29718450
Inflamm Bowel Dis. 2012 Jan;18(1):74-84
pubmed: 21438095
Aliment Pharmacol Ther. 2014 Jul;40(2):134-46
pubmed: 24912799
Abdom Imaging. 2009 Jul;34(4):467-75
pubmed: 18551336
Clin Gastroenterol Hepatol. 2017 Apr;15(4):535-542.e2
pubmed: 27856365
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):13761-6
pubmed: 14610281
RMD Open. 2019 Mar 8;5(1):e000795
pubmed: 30997148
J Crohns Colitis. 2017 May 1;11(5):556-561
pubmed: 28453758
Inflamm Bowel Dis. 2016 May;22(5):1246-61
pubmed: 27070909
Inflamm Bowel Dis. 2018 Apr 23;24(5):932-942
pubmed: 29668919
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Am J Gastroenterol. 2015 Sep;110(9):1324-38
pubmed: 26303131
J Crohns Colitis. 2015 Sep;9(9):795-801
pubmed: 26079723
Inflamm Bowel Dis. 2018 Jan 18;24(2):440-449
pubmed: 29361096
Gut. 2018 May;67(5):973-985
pubmed: 29437914
Lancet Gastroenterol Hepatol. 2018 Aug;3(8):548-558
pubmed: 29914843
J Crohns Colitis. 2018 Jul 30;12(8):920-929
pubmed: 29684200
JGH Open. 2019 Oct 09;4(2):267-272
pubmed: 32280776
Gut. 1989 Jul;30(7):983-9
pubmed: 2668130
J Crohns Colitis. 2021 Jan 13;15(1):125-142
pubmed: 32614386
Gut. 2016 Jul;65(7):1119-25
pubmed: 25935574
AJR Am J Roentgenol. 2013 Dec;201(6):1220-8
pubmed: 24261360
Gut. 2009 Aug;58(8):1113-20
pubmed: 19136510
J Crohns Colitis. 2018 Jan 5;12(1):48-56
pubmed: 28981627
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571